KFSH&RC Scientists Unveil 'Riyadhensis', A New Bacterial Species, Through WGS Technology

Scientists at the King Faisal Specialist Hospital and Research Centre (KFSH&RC) have made a significant breakthrough in the field of microbiology by identifying a new species of bacteria, named "Stenotrophomonas Riyadhensis". This discovery, achieved through the use of whole-genome sequencing (WGS) technology, offers critical insights into bacterial behavior and resistance, potentially leading to the development of new therapeutic strategies. The findings underscore KFSH&RC's role in pushing the frontiers of scientific research and enhancing patient care.

The identification of Stenotrophomonas Riyadhensis marks a crucial step forward in understanding bacterial resistance mechanisms, especially in high-risk settings such as intensive care units (ICUs) and among immunocompromised patients. This advancement is seen as a significant contribution to the global fight against antibiotic-resistant bacteria, highlighting the importance of genomic tests in developing innovative diagnostic and therapeutic methods.

The discovery emerged from an investigation into a suspected outbreak in the KFSH&RC ICU back in 2019. Initially believed to be a variant of Pseudomonas aeruginosa, a bacterium notorious for its resistance to antibiotics, subsequent WGS analysis revealed that it did not belong to the Pseudomonas genus. Instead, it was identified as a member of the Stenotrophomonas family, with distinct genetic and morphological characteristics.

Dr. Ahmad Al Qahtani, Head of the Infectious Disease and Immunity Department at KFSH&RC, emphasized the superiority of WGS analysis over traditional bacterial identification methods. He stated that WGS provides a more precise and targeted approach, ensuring accurate identification and offering detailed insights into resistance mechanisms. This precision is crucial for investigating disease outbreaks and improving patient care outcomes.

Dr. Reem Almaghrabi, head of Transplant Infectious Diseases at the Organ Transplant Centre of Excellence at KFSH&RC, also highlighted the significance of this discovery. She pointed out that continuous monitoring and the adoption of advanced technologies like WGS are essential for developing faster and more accurate diagnostic methods. Almaghrabi stressed that understanding new bacterial species and their resistance patterns is vital in modern healthcare, as these evolving bacteria pose an ongoing threat to human health.

This breakthrough not only showcases KFSH&RC's commitment to advancing medical science but also emphasizes the critical role of genomic testing in combating antibiotic resistance. The discovery of Stenotrophomonas Riyadhensis opens up new avenues for research and collaboration, aiming to improve global health outcomes.

With inputs from SPA